KHERION Trademark

Trademark Overview


On Thursday, April 4, 2019, a trademark application was filed for KHERION with the United States Patent and Trademark Office. The USPTO has given the KHERION trademark a serial number of 79267807. The federal status of this trademark filing is REGISTERED as of Tuesday, July 13, 2021. This trademark is owned by Kherion Technology Limited. The KHERION trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical, medical and veterinary preparations and substances for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical, med...

Electronic data in recorded form and downloadable electronic publications in the nature of reports, articles, e-books and e-zines relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances

Scientific and technological services and research and design relating thereto relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances; research in the field of molecular biology; pharmaceutical, medical and veterinary research; industrial analysis in the biological, pharmaceutical, medical, and veterinary fields; industrial research services in the fields of pharmaceuticals, medicine and science; research, development, testing and evaluation of pharmaceuticals and of pharmaceutical, medical and veterinary preparations and substances; research, development, testing and evaluation of enzymes and of diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; provision of information and consultancy in relation to any of the aforesaid services
kherion

General Information


Serial Number79267807
Word MarkKHERION
Filing DateThursday, April 4, 2019
Status700 - REGISTERED
Status DateTuesday, July 13, 2021
Registration Number6413425
Registration DateTuesday, July 13, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical, medical and veterinary preparations and substances for the treatment and prevention of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, cardiovascular diseases or disorders, metabolic diseases or disorders, inflammation, cancer, and diabetes; pharmaceutical, medical and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders; enzymes for medical and veterinary purposes; vaccines; diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, blood fraction proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases or disorders, namely, human plasma proteins; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, animal plasma proteins; gene regulatory proteins for medical use; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, namely, antibodies; antibody receptors for medical use; antigens for medical use; antigen receptors for medical use; sanitary preparations for medical and veterinary purposes; preparations for destroying vermin; fungicides, herbicides; molecular components and complexes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Goods and ServicesElectronic data in recorded form and downloadable electronic publications in the nature of reports, articles, e-books and e-zines relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances
Goods and ServicesScientific and technological services and research and design relating thereto relating to enzymes, vaccines, pharmaceuticals and pharmaceutical, medical and veterinary preparations and substances; research in the field of molecular biology; pharmaceutical, medical and veterinary research; industrial analysis in the biological, pharmaceutical, medical, and veterinary fields; industrial research services in the fields of pharmaceuticals, medicine and science; research, development, testing and evaluation of pharmaceuticals and of pharmaceutical, medical and veterinary preparations and substances; research, development, testing and evaluation of enzymes and of diagnostic agents, reagents, preparations and substances for pharmaceutical, medical and veterinary purposes; provision of information and consultancy in relation to any of the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateTuesday, October 1, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 1, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKherion Technology Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameKherion Technology Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameKherion Technology Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, November 15, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, October 24, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 23, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 13, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, June 3, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 27, 2021LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Saturday, April 17, 2021LIMITATION OF GOODS RECEIVED FROM IB
Saturday, April 17, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, March 13, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 24, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, December 12, 2020NOTIFICATION PROCESSED BY IB
Tuesday, November 24, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Saturday, November 21, 2020NOTIFICATION PROCESSED BY IB
Wednesday, November 4, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 4, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 16, 2020EXAMINER'S AMENDMENT ENTERED
Friday, October 16, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT E-MAILED
Friday, October 16, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 27, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 27, 2020FINAL REFUSAL E-MAILED
Wednesday, May 27, 2020FINAL REFUSAL WRITTEN
Tuesday, April 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 22, 2019REFUSAL PROCESSED BY IB
Saturday, November 2, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 2, 2019REFUSAL PROCESSED BY MPU
Wednesday, October 16, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 15, 2019NON-FINAL ACTION WRITTEN
Saturday, October 5, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, October 1, 2019ASSIGNED TO EXAMINER
Tuesday, October 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB